Genetic Variation as a Guide to Drug Development
- 18 September 1998
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 281 (5384), 1820-1821
- https://doi.org/10.1126/science.281.5384.1820
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A Genome Survey for Novel Alzheimer Disease Risk Loci: Results at 10-cM ResolutionGenomics, 1998
- ProteomicsNature Biotechnology, 1998
- −455G/A Polymorphism of the β-Fibrinogen Gene is Associated With the Progression of Coronary Atherosclerosis in Symptomatic MenArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary AtherosclerosisThe New England Journal of Medicine, 1998
- Laser Capture MicrodissectionScience, 1996
- Genomic sciences and the medicine of tomorrowNature Biotechnology, 1996
- Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapineNeuroscience Letters, 1996
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical SignificanceDrug Metabolism Reviews, 1979